Inhibikase Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inhibikase Therapeutics, Inc.
CIK #0001750149
EDGAR Form CIK 2011 - 2025
10-K [0001750149]
10-Q [0001750149]
3 [0001750149]
4 [0001750149]
8-K [0001750149]
D [0001750149]
SC 13D [0001750149]
SC 13G [0001750149]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Management LLC Inhibikase Therapeutics Inc [2025-02-14]
Adar1 Capital Management LLC Inhibikase Therapeutics Inc [2025-02-14]
Armistice Capital LLC Inhibikase Therapeutics Inc [2024-11-14]
Soleus Private Equity Fund III LP Inhibikase Therapeutics Inc [2024-10-28]
SP IKT Holdings LLC Inhibikase Therapeutics Inc [2024-10-28]
Sands Capital Life Sciences Pulse Fund II LP Inhibikase Therapeutics Inc [2024-10-25]
Perceptive Advisors LLC Inhibikase Therapeutics Inc [2024-10-22]
Fairmount Funds Management LLC Inhibikase Therapeutics Inc [2024-10-17]
Commodore Capital LP Inhibikase Therapeutics Inc [2024-10-17]
Point72 Asset Management LP Inhibikase Therapeutics Inc [2024-10-10]
View All
Form 3/4/5 Subject 2011 - 2025
Bellini Roberto
Inhibikase Therapeutics, Inc.
Canner David
Munshi Amit
Aurentz Vincent
Kush Arvind
Berman Dennis N
McIntyre David
Iwicki Mark T
Cabell Christopher
Freeman Roy Lester
Werner Milton H.
Lees-Rolfe Garth
Sands Capital Life Sciences Pulse Fund II, L.P.
Sands Frank M
Sands Capital Alternatives, LLC
Dion Gisele
Grint Paul C
Frattaroli Joseph
O'Farrell Elizabeth G.
Kalman Daniel
Terms | Privacy | Guide
tony@aum13f.com